PeopleBio, Inc. (KOSDAQ:304840)

Market Cap	16.07B -72.0%
Revenue (ttm)	3.36B -23.3%
Net Income	-7.15B
EPS	-328.85
Shares Out	21.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	568,354
Average Volume	572,983
Open	807.00
Previous Close	800.00
Day's Range	750.00 - 841.00
52-Week Range	708.00 - 3,375.00
Beta	0.17
RSI	25.68
Earnings Date	Mar 20, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Employees: 46
• Stock Exchange: KOSDAQ
• Ticker Symbol: 304840

Financial Performance

In 2024, PeopleBio's revenue was 3.73 billion, a decrease of -16.20% compared to the previous year's 4.45 billion. Losses were -10.91 billion, -31.94% less than in 2023.